• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝纤维化中的遗传决定因素:从实验模型到人类的纤维化基因特征

Genetic determinants in hepatic fibrosis: from experimental models to fibrogenic gene signatures in humans.

作者信息

Weber Susanne, Gressner Olav A, Hall Rabea, Grünhage Frank, Lammert Frank

机构信息

Department of Medicine II, Saarland University Hospital, Saarland University, Homburg/Saar, Germany.

出版信息

Clin Liver Dis. 2008 Nov;12(4):747-57, vii. doi: 10.1016/j.cld.2008.07.012.

DOI:10.1016/j.cld.2008.07.012
PMID:18984464
Abstract

Hepatic fibrosis, or scarring of the liver, is a nonspecific reaction to chronic liver injury. Hepatic fibrosis is commonly caused by exogenous factors such as viral hepatitis or alcohol abuse, but recent studies also indicate a genetic predisposition. Although some patients who have chronic liver diseases show only minor morphologic and functional alterations of the liver and are characterized by slow progression of disease with mild clinical symptoms, others develop pronounced hepatic fibrosis rapidly, culminating in cirrhosis, liver failure, or hepatocellular carcinoma, respectively. These well known differences in progression of hepatic fibrosis persist when controlling for age (at infection), gender, and exogenous factors in multivariate analysis, indicating that genetic factors might play important roles in the modulation of hepatic fibrosis and contribute to the variability in fibrosis progression. This review summarizes genetic determinants in hepatic fibrosis.

摘要

肝纤维化,即肝脏瘢痕形成,是对慢性肝损伤的一种非特异性反应。肝纤维化通常由诸如病毒性肝炎或酒精滥用等外源性因素引起,但最近的研究也表明存在遗传易感性。虽然一些患有慢性肝病的患者仅表现出肝脏轻微的形态学和功能改变,其疾病进展缓慢且临床症状较轻,但另一些患者则迅速发展为明显的肝纤维化,最终分别导致肝硬化、肝衰竭或肝细胞癌。在多变量分析中,当控制年龄(感染时)、性别和外源性因素时,肝纤维化进展的这些众所周知的差异依然存在,这表明遗传因素可能在肝纤维化的调节中起重要作用,并导致纤维化进展的变异性。本综述总结了肝纤维化中的遗传决定因素。

相似文献

1
Genetic determinants in hepatic fibrosis: from experimental models to fibrogenic gene signatures in humans.肝纤维化中的遗传决定因素:从实验模型到人类的纤维化基因特征
Clin Liver Dis. 2008 Nov;12(4):747-57, vii. doi: 10.1016/j.cld.2008.07.012.
2
[Genetic risk factors for hepatic fibrosis in chronic liver diseases].[慢性肝病中肝纤维化的遗传危险因素]
Med Klin (Munich). 2003 Dec 15;98(12):754-62. doi: 10.1007/s00063-003-1324-3.
3
Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15.近交系小鼠肝纤维化的全基因组分析确定了15号染色体上的易感性位点Hfib1。
Gastroenterology. 2002 Dec;123(6):2041-51. doi: 10.1053/gast.2002.37069.
4
[Genome-wide association studies in hepatology].[肝脏病学中的全基因组关联研究]
Z Gastroenterol. 2010 Jan;48(1):56-64. doi: 10.1055/s-0028-1109982. Epub 2010 Jan 13.
5
Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans.补体因子5是一种数量性状基因,可调节小鼠和人类的肝脏纤维化。
Nat Genet. 2005 Aug;37(8):835-43. doi: 10.1038/ng1599. Epub 2005 Jul 3.
6
Genomics of liver fibrosis and cirrhosis.肝纤维化和肝硬化的基因组学
Semin Liver Dis. 2007 Feb;27(1):28-43. doi: 10.1055/s-2006-960169.
7
Liver fibrosis: from animal models to mapping of human risk variants.肝纤维化:从动物模型到人类风险变异体的映射。
Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):635-46. doi: 10.1016/j.bpg.2010.07.013.
8
Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.疾病机制:肝纤维化的机制及治疗意义
Nat Clin Pract Gastroenterol Hepatol. 2004 Dec;1(2):98-105. doi: 10.1038/ncpgasthep0055.
9
Genetics of liver injury and fibrosis.肝脏损伤和纤维化的遗传学。
Alcohol Clin Exp Res. 2011 May;35(5):800-3. doi: 10.1111/j.1530-0277.2010.01401.x. Epub 2011 Feb 1.
10
Hepatic fibrosis -- overview.肝纤维化——概述。
Toxicology. 2008 Dec 30;254(3):120-9. doi: 10.1016/j.tox.2008.06.013. Epub 2008 Jul 10.

引用本文的文献

1
Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances.肝纤维化和肝炎的药物治疗:最新进展
Pharmaceuticals (Basel). 2024 Dec 20;17(12):1724. doi: 10.3390/ph17121724.
2
The Genetic Architecture of Carbon Tetrachloride-Induced Liver Fibrosis in Mice.小鼠四氯化碳诱导肝纤维化的遗传结构。
Cell Mol Gastroenterol Hepatol. 2021;11(1):199-220. doi: 10.1016/j.jcmgh.2020.08.010. Epub 2020 Aug 28.
3
Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis.阐明新兴生物标志物早期预测肝纤维化的潜在抗纤维化机制。
Int J Mol Sci. 2020 Jul 3;21(13):4737. doi: 10.3390/ijms21134737.
4
Astaxanthin as a Potential Protector of Liver Function: A Review.虾青素作为肝功能潜在保护剂的综述
J Clin Med Res. 2016 Oct;8(10):701-4. doi: 10.14740/jocmr2672w. Epub 2016 Aug 30.
5
Mouse genetic background contributes to hepatocyte susceptibility to Fas-mediated apoptosis.小鼠遗传背景影响肝细胞对Fas介导的细胞凋亡的易感性。
Mol Biol Cell. 2016 Oct 15;27(20):3005-3012. doi: 10.1091/mbc.E15-06-0423. Epub 2016 Aug 17.
6
TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.Toll样受体4缺陷可预防肝纤维化及二乙基亚硝胺诱导的纤维化肝脏的癌前肝损伤。
PLoS One. 2016 Jul 8;11(7):e0158819. doi: 10.1371/journal.pone.0158819. eCollection 2016.
7
Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective.用于肝病中药研究的临床前模型:更新与展望
Evid Based Complement Alternat Med. 2016;2016:4750163. doi: 10.1155/2016/4750163. Epub 2016 Jan 28.
8
Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.基于前瞻性双胞胎研究的肝纤维化和脂肪变性的遗传性。
Gastroenterology. 2015 Dec;149(7):1784-93. doi: 10.1053/j.gastro.2015.08.011. Epub 2015 Aug 20.
9
Systems genetics of liver fibrosis: identification of fibrogenic and expression quantitative trait loci in the BXD murine reference population.肝纤维化的系统遗传学:在BXD小鼠参考群体中鉴定纤维化和表达数量性状基因座
PLoS One. 2014 Feb 28;9(2):e89279. doi: 10.1371/journal.pone.0089279. eCollection 2014.
10
Experimental liver fibrosis research: update on animal models, legal issues and translational aspects.实验性肝纤维化研究:动物模型、法律问题及转化医学方面的最新进展
Fibrogenesis Tissue Repair. 2013 Oct 1;6(1):19. doi: 10.1186/1755-1536-6-19.